Low-Voltage Areas as Alternative Targets for the Ablation of Unmappable Atrial Tachycardia in Patients Undergoing Atrial Fibrillation Ablation.

Atrial fibrillation Low-voltage area Unmappable atrial tachyarrhythmia

Journal

Journal of atrial fibrillation
ISSN: 1941-6911
Titre abrégé: J Atr Fibrillation
Pays: United States
ID NLM: 101514767

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 21 04 2019
revised: 16 06 2019
accepted: 20 07 2019
entrez: 24 12 2021
pubmed: 31 8 2020
medline: 31 8 2020
Statut: epublish

Résumé

Unmappable regular atrial tachycarrhythmias (ATs) occasionally develop during atrial fibrillation (AF) ablation, and are difficult to treat by conventional ablation. Recently, low-voltage areas (LVAs) have been reported to represent AT substrate. The purpose of this study was to elucidate the efficacy of LVA ablation for unmappable AT. This observational study included 32 consecutive patients who developed unmappable ATs during and after AF ablation. Unmappable AT was defined as AT lasting for >5 s, but that terminated or changed the activation sequence over too short a time to create a sufficient activation map. We used conventional ablation to target undetermined AT circuits estimated from activation timings of electrograms recorded on the placed electrode catheter, the response to entrainment mappings, and/or diastolic potentials during AT. Subsequently, in cases without successful elimination of unmappable ATs by conventional ablation, LVA (≤ 0.5 mV) ablation was performed at the discretion of the operators. Conventional ablation failed to eliminate at least one unmappable AT in 29 patients. Among them, LVA ablation was performed in 16 patients. LVA ablation eliminated all the unmappable ATs in 8 of 16 patients. The LVA size did not differ between patients with and without the acute elimination of unmappable ATs (17±11 vs. 21±12 cm2, p = 0.39), and AT/AF recurrence rates were comparable between the two groups (38% vs. 63%, p = 0.62) during a mean follow-up period of 14±8 months. LVA ablation was efficacious to some extent for the elimination of unmappable ATs refractory to conventional ablation.

Identifiants

pubmed: 34950285
doi: 10.4022/jafib.2165
pmc: PMC8691316
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2165

Références

Circulation. 2004 Sep 14;110(11):1351-7
pubmed: 15353501
Int J Cardiol. 2018 Apr 15;257:97-101
pubmed: 29506746
Circulation. 1996 Oct 1;94(7):1600-6
pubmed: 8840850
Circ Arrhythm Electrophysiol. 2014 Oct;7(5):825-33
pubmed: 25151631
Heart Rhythm. 2012 Oct;9(10):1660-6
pubmed: 22683745
J Cardiovasc Electrophysiol. 2019 Jun;30(6):865-876
pubmed: 30834593
Circ Arrhythm Electrophysiol. 2015 Jun;8(3):537-45
pubmed: 25792508
Circ Arrhythm Electrophysiol. 2017 Jan;10(1):
pubmed: 28039280
Pacing Clin Electrophysiol. 2019 May;42(5):515-520
pubmed: 30882916
Heart Rhythm. 2016 Apr;13(4):870-8
pubmed: 26711800
Europace. 2009 Dec;11(12):1597-605
pubmed: 19910315
J Cardiovasc Electrophysiol. 2016 Sep;27(9):1055-63
pubmed: 27235000
Heart Rhythm. 2013 Aug;10(8):1184-91
pubmed: 23685170
Circ Arrhythm Electrophysiol. 2008 Apr;1(1):62-73
pubmed: 19808395
Biophys J. 2009 Oct 21;97(8):2179-90
pubmed: 19843450
Circulation. 2009 Apr 7;119(13):1758-67
pubmed: 19307477
J Am Coll Cardiol. 2004 Jun 16;43(12):2260-4
pubmed: 15193690

Auteurs

Masaharu Masuda (M)

Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabaso, Amagasaki, Hyogo 660-8511, Japan.

Mitsutoshi Asai (M)

Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabaso, Amagasaki, Hyogo 660-8511, Japan.

Osamu Iida (O)

Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabaso, Amagasaki, Hyogo 660-8511, Japan.

Shin Okamoto (S)

Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabaso, Amagasaki, Hyogo 660-8511, Japan.

Takayuki Ishihara (T)

Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabaso, Amagasaki, Hyogo 660-8511, Japan.

Kiyonori Nanto (K)

Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabaso, Amagasaki, Hyogo 660-8511, Japan.

Takashi Kanda (T)

Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabaso, Amagasaki, Hyogo 660-8511, Japan.

Takuya Tsujimura (T)

Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabaso, Amagasaki, Hyogo 660-8511, Japan.

Yasuhiro Matsuda (Y)

Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabaso, Amagasaki, Hyogo 660-8511, Japan.

Shota Okuno (S)

Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabaso, Amagasaki, Hyogo 660-8511, Japan.

Toshiaki Mano (T)

Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabaso, Amagasaki, Hyogo 660-8511, Japan.

Classifications MeSH